logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Spinal Cord Diseases

    FiltersReset Filters
    7 results

    • baclofen

      (Baclofen)
      Palmetto Pharmaceuticals Inc.
      Usage: Baclofen oral solution is indicated for treating spasticity due to multiple sclerosis, providing relief from flexor spasms, pain, clonus, and muscular rigidity. It may be beneficial for patients with spinal cord injuries and similar conditions, but is not indicated for skeletomuscular spasms from rheumatic disorders.

    • baclofen

      (Baclofen)
      Mylan Pharmaceuticals Inc.
      Usage: Baclofen Injection is indicated for managing severe spasticity, particularly in patients with spinal cord injuries or cerebral palsy, who have not responded to oral baclofen. It is used intrathecally via a screening dose and long-term through FDA-approved implantable pumps, following positive initial responses.

    • baclofen

      (Baclofen)
      Sarras Health LLC
      Usage: Baclofen oral solution is indicated for treating spasticity from multiple sclerosis, relieving flexor spasms, pain, clonus, and muscular rigidity. It may benefit patients with spinal cord injuries and diseases but is not intended for muscle spasms due to rheumatic disorders.

    • baclofen

      (BACLOFEN)
      XLCare Pharmaceuticals Inc.
      Usage: Baclofen tablets USP are indicated for alleviating spasticity from multiple sclerosis, particularly flexor spasms, pain, clonus, and muscular rigidity. They may also benefit patients with spinal cord injuries. Baclofen is not indicated for rheumatic disorders or conditions like stroke, cerebral palsy, or Parkinson's disease.

    • baclofen

      (Baclofen)
      Chartwell RX, LLC
      Usage: Baclofen tablets are indicated for alleviating spasticity symptoms from multiple sclerosis, including flexor spasms, pain, clonus, and muscular rigidity. They may benefit patients with spinal cord injuries but are not effective for rheumatic disorders, strokes, cerebral palsy, or Parkinson's disease.

    • baclofen

      (Baclofen)
      Marlex Pharmaceuticals Inc
      Usage: Baclofen tablets USP are indicated for alleviating spasticity due to multiple sclerosis, relieving flexor spasms, pain, clonus, and muscular rigidity. They may also benefit patients with spinal cord injuries or diseases. Baclofen is not indicated for rheumatic disorders or conditions like stroke, cerebral palsy, and Parkinson’s disease.

    • gadoterate meglumine

      (gadoterate meglumine)
      Fresenius Kabi USA, LLC
      Usage: Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use during MRI to detect and visualize disruptions of the blood-brain barrier and abnormal vascularity in the brain, spine, and associated tissues in both adult and pediatric patients, including term neonates.